SEC 13F Intelligence

Ramsay, Stattman, Vela & Price, Inc. / ABT

Ramsay, Stattman, Vela & Price, Inc.’s Abbott Laboratories Position

Does Ramsay, Stattman, Vela & Price, Inc. own Abbott Laboratories (ABT)? Yes — 102.4K shares worth $11M (+2.08% of its 13F portfolio) as of Q1 2026, down from 110.6K shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
102.4K
% of Portfolio
+2.08%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $10MQ4 ’18Q1 ’19: $10MQ2 ’19: $11MQ3 ’19: $10MQ4 ’19: $11MQ4 ’19Q1 ’20: $10MQ2 ’20: $11MQ3 ’20: $13MQ4 ’20: $13MQ4 ’20Q1 ’21: $14MQ2 ’21: $13MQ3 ’21: $13MQ4 ’21: $16MQ4 ’21Q1 ’22: $13MQ2 ’22: $12MQ3 ’22: $11MQ4 ’22: $12MQ4 ’22Q1 ’23: $11MQ2 ’23: $12MQ3 ’23: $11MQ4 ’23: $12MQ4 ’23Q1 ’24: $12MQ2 ’24: $11MQ3 ’24: $12MQ4 ’24: $13MQ4 ’24Q1 ’25: $15MQ2 ’25: $15MQ3 ’25: $14MQ4 ’25: $14MQ4 ’25Q1 ’26: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026102.4K$11M+2.08%
Q4 2025110.6K$14M+2.50%
Q3 2025107.8K$14M+2.59%
Q2 2025108.3K$15M+2.75%
Q1 2025112.0K$15M+2.82%
Q4 2024111.1K$13M+2.34%
Q3 2024104.7K$12M+2.22%
Q2 2024106.7K$11M+2.10%
Q1 2024107.1K$12M+2.33%
Q4 2023109.2K$12M+2.45%
Q3 2023110.9K$11M+2.33%
Q2 2023112.7K$12M+2.50%
Q1 2023113.3K$11M+2.48%
Q4 2022112.6K$12M+2.79%
Q3 2022113.3K$11M+2.72%
Q2 2022113.7K$12M+2.77%
Q1 2022113.2K$13M+2.61%
Q4 2021113.3K$16M+3.62%
Q3 2021113.9K$13M+3.35%
Q2 2021114.3K$13M+3.28%
Q1 2021116.9K$14M+3.72%
Q4 2020117.2K$13M+3.61%
Q3 2020119.1K$13M+4.02%
Q2 2020118.8K$11M+3.75%
Q1 2020123.0K$10M+3.82%
Q4 2019124.1K$11M+3.45%
Q3 2019123.8K$10M+3.59%
Q2 2019125.6K$11M+3.77%
Q1 2019129.3K$10M+3.77%
Q4 2018131.4K$10M+3.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ramsay, Stattman, Vela & Price, Inc.’s full portfolio or all institutional holders of ABT.